Impaired neurosteroid synthesis in multiple sclerosis

Area of Science:

• Neuroscience
• Molecular Biology
• Immunology

Background:

• Multiple sclerosis (MS) is a complex inflammatory neurological disorder.
• Micro-RNAs (miRNAs) play crucial roles in regulating gene expression and cellular processes.
• Understanding miRNA involvement in MS pathogenesis is vital for developing new therapies.

Purpose of the Study:

• To investigate the impact of micro-RNAs on neurosteroid synthesis in multiple sclerosis.
• To identify specific miRNAs and neurosteroids dysregulated in MS.
• To evaluate the therapeutic potential of allopregnanolone in an MS model.

Main Methods:

• Micro-RNA profiling of cerebral white matter from MS patients and controls.
• Confirmatory analyses: RT-PCR, immunoblotting, GC-MS.
• In vivo studies using the experimental autoimmune encephalomyelitis (EAE) mouse model.
• Luciferase assays and in situ hybridization for miRNA validation.

Main Results:

• Differential miRNA expression observed in MS brains, with specific miRNAs (miR-338, miR-155, miR-491) upregulated.
• Suppressed neurosteroidogenic enzyme and allopregnanolone levels in MS white matter.
• Similar molecular changes and allopregnanolone reduction observed in EAE mice.
• Allopregnanolone treatment ameliorated neuropathology and neurobehavioral deficits in EAE mice.

Conclusions:

• Impaired neurosteroidogenesis is a key feature of multiple sclerosis and its animal model.
• Allopregnanolone shows promise as a potential therapeutic agent for MS.
• Neurosteroids may serve as valuable biomarkers for multiple sclerosis.